메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

쭐랄롱꼰대 개발 AI '딥 GI', 위장관암 진단 혁신 기대

[ 메디채널 김갑성 기자 ] 방콕 2025년 12월 2일 -- 쭐랄롱꼰대학교 의과대학이 공과대학과 협력해 '딥 GI(Deep GI)'라는 혁신적인 인공지능(AI) 기술을 개발했다. 이 기술은 일반의가 전문의와 동등한 수준으로 위장관암(胃腸管癌)을 발견하는 데 도움을 줄 수 있게 설계됐다. 수십만 건의 내시경 영상으로 훈련된 이 시스템은 태국 식품의약품국(Thai FDA) 승인을 획득해 현재 전국 배포 및 상업화 준비를 진행 중이다. 대장암은 태국인들 사이에서 세 번째로 흔한 암으로, 특히 50세 이상이 고위험군에 속한다. 그러나 태국에는 내시경 전문의가 약 1000명에 불과해 검진 수요를 충족할 만큼 잘 훈련된 전문 인력이 부족하다. 딥 GI는 내시경 검사 시 폴립(용종)과 같은 비정상 병변을 실시간으로 표시해주는 '조력자(co-pilot)' 역할을 수행하며 이러한 격차를 해소하는 데 도움을 준다. 이를 통해 의사는 보다 자신감 있고 효율적으로 최종 진단을 내릴 수 있게 된다. 2022년 완료된 딥 GI 1단계는 대장암 검출에 집중했다. 1단계의 성공은 2025년 6월 딥 GI 2단계 출시로 이어졌다. 2단계에서는
- 김갑성 기자
- 2025-12-02 10:45
Leaders Dental Accelerates Global Expansion With AI-CAD and 3D Printing-Based Surgical Guides

SEOUL, South Korea, Dec. 2, 2025 -- Leaders Dental Laboratory (branded globally as LEADERS DENTAL), a leading digital dental laboratory in Korea, is rapidly strengthening its presence in the global digital dentistry market with its flagship product, the surgical guide. Backed by recent export achievements in five countries—including the United Kingdom, Japan, and Taiwan—the company is expanding exports of its integrated digital solution packages to align with the global shift from single implant components to fully systemized workflows. LEADERS DENTAL operates a large-scale digital man
- 김갑성 기자
- 2025-12-02 08:00
Suchang Accelerates Global Expansion With Dog Food Made From Jeju Citrus By-products

SEOUL, South Korea, Dec. 2, 2025 -- Suchang a Korean manufacturer specializing in over 150 types of natural bio-based ingredients and overseas distribution consulting, announced that it has successfully developed a new dog food product using gamgyul-bak—by-products from Jeju's citrus processing industry. Tentatively branded as "Orange Dogs," the new product is designed for global markets, with export plans targeting the United States, Japan, China, and Europe. Originally operating as a B2B-focused bio-raw material manufacturer, Suchang has launched the "Orange Dogs"
- 김갑성 기자
- 2025-12-02 08:00
Lynk Pharmaceuticals Announces FDA IND Approval of Its Allosteric TYK2 Inhibitor LNK01006

HANGZHOU, China and SHANGHAI and BOSTON, Dec. 2, 2025 -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on developing innovative therapies for immune and inflammatory diseases, today announced that its innovative TYK2 allosteric inhibitor, LNK01006, has been approved by U.S. Food and Drug Administration (FDA) for human clinical trials. LNK01006 is a highly brain-penetrant, potent, and selective oral TYK2 allosteric inhibitor targeting the JH2 domain. TYK2 is a key regulator of th
- 김갑성 기자
- 2025-12-02 08:00
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence

LYON, France, Dec. 2, 2025 -- NEJM Evidence, a journal of the New England Journal of Medicine Group, has published an article titled "Validation of a Saliva microRNA Signature for Endometriosis," dedicated to the saliva-based diagnostic test developed by Ziwig. The publication reports the results of a prospective, independent, multicenter clinical study conducted in France. The study enrolled 971 symptomatic women aged 18 to 43 years across 17 public and private hospitals. High-performance saliva-based diagnosis The Ziwig Endotest® was evaluated thro
- 김갑성 기자
- 2025-12-02 06:00
Building Families with Innovation: Patient-First Vision Goes Digital

SYDNEY, Dec. 2, 2025 -- Miroma Project Factory (MPF) was delighted to welcome Westmead Fertility Centre to the agency fold for a wide-reaching digital transformation initiative. The engagement began with a comprehensive audit of Westmead Fertility Centre's digital infrastructure to identify opportunities across systems, tools, and platforms to deliver a truly patient-focused experience. This discovery phase included detailed user and stakeholder research, which has informed a robust patient-led digital transformation. Spearheaded by MPF's CEO and Technical Strategist, Kat Robinson and her tea
- 김갑성 기자
- 2025-12-02 05:07
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025

BELLEVUE, Wash., Dec. 2, 2025 -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that management will present at the upcoming Emerging Growth Conference. This presentation will provide investors and analysts with an updated overview of OSR Holdings' diversified healthcare platforms and strategic growth initiatives. Virtual Presentation Details Date: December 10, 2025 Time: 9:05 a.m. ET Format: Corporate Overview Registration Link: https://goto.
- 김갑성 기자
- 2025-12-02 04:01
CQ Medical® Expands Radiation Therapy Portfolio With Bionix Business Unit Acquisition

AVONDALE, Pa., Dec. 2, 2025 -- CQ Medical, the global leader in patient radiotherapy positioning and healthcare innovation, is proud to announce the acquisition of Bionix's Radiation Therapy business unit, marking an expansion of its patient positioning and marking product portfolio. The acquisition reinforces CQ Medical's mission to advance precision in radiotherapy, empowering clinicians and improving outcomes worldwide. Bionix has established a strong reputation of developing innovative, high-quality medical devices across multiple patient care segments for over 40 years. Following
- 김갑성 기자
- 2025-12-02 02:07
United Imaging Broadens Imaging Portfolio and Advances Native AI at RSNA 2025

[ 메디채널 김갑성 기자 ] The company brings a full array of technology to its two booths in Chicago, showcasing another year of increasing R&D and investment. CHICAGO, Dec. 2, 2025 -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will showcase a range of cutting-edge technologies at RSNA 2025. Under the theme "Passion for Change, For One and All," the company will highlight how its technology is built to see the uniqueness of each individual and extend access to advanced care across different communities. The portfolio on d
- 김갑성 기자
- 2025-12-02 00:00
The Frost & Sullivan Institute Honors Global Organizations Pioneering Responsible Growth With the 2025 Visionary Growth Leadership Best Practices Recognition

SANTA CLARA, Calif., Dec. 1, 2025 -- The Frost & Sullivan Institute is proud to announce the recipients of the 2025 Visionary Growth Leadership Best Practices Recognition, celebrating organizations that exemplify purpose-driven innovation, sustainable business models, and leadership committed to creating a positive global impact. This recognition highlights the companies that are spearheading meaningful change and addressing the global priorities identified by the Frost & Sullivan Institute. "The Visionary Growth Leadership Best Practices Recognition celebrates companies t
- 김갑성 기자
- 2025-12-01 22:40

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-12-02_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 02일 12시 10분